Dubar, V.; Pascreau, T.; Dupont, A.; Dubucquoi, S.; Dautigny, A.-L.; Ghozlan, B.; Zuber, B.; Mellot, F.; Vasse, M.; Susen, S.;
et al. Development of a Decision Support Tool for Anticoagulation in Critically Ill Patients Admitted for SARS-CoV-2 Infection: The CALT Protocol. Biomedicines 2023, 11, 1504.
https://doi.org/10.3390/biomedicines11061504
AMA Style
Dubar V, Pascreau T, Dupont A, Dubucquoi S, Dautigny A-L, Ghozlan B, Zuber B, Mellot F, Vasse M, Susen S,
et al. Development of a Decision Support Tool for Anticoagulation in Critically Ill Patients Admitted for SARS-CoV-2 Infection: The CALT Protocol. Biomedicines. 2023; 11(6):1504.
https://doi.org/10.3390/biomedicines11061504
Chicago/Turabian Style
Dubar, Victoria, Tiffany Pascreau, Annabelle Dupont, Sylvain Dubucquoi, Anne-Laure Dautigny, Benoit Ghozlan, Benjamin Zuber, François Mellot, Marc Vasse, Sophie Susen,
and et al. 2023. "Development of a Decision Support Tool for Anticoagulation in Critically Ill Patients Admitted for SARS-CoV-2 Infection: The CALT Protocol" Biomedicines 11, no. 6: 1504.
https://doi.org/10.3390/biomedicines11061504
APA Style
Dubar, V., Pascreau, T., Dupont, A., Dubucquoi, S., Dautigny, A.-L., Ghozlan, B., Zuber, B., Mellot, F., Vasse, M., Susen, S., Poissy, J., & Gaudet, A.
(2023). Development of a Decision Support Tool for Anticoagulation in Critically Ill Patients Admitted for SARS-CoV-2 Infection: The CALT Protocol. Biomedicines, 11(6), 1504.
https://doi.org/10.3390/biomedicines11061504
